Trading of Nanobiotix was halted at 09:30 AM EST due to "LULD pause". Nanobiotix (NBTX) Institutional Ownership $5.82 +0.74 (+14.44%) Closing price 03:58 PM EasternExtended Trading$5.85 +0.02 (+0.43%) As of 04:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Nanobiotix (NASDAQ:NBTX)CurrentInstitutional OwnershipPercentage38.81%Number ofInstitutional Buyers(last 12 months)4TotalInstitutional Inflows(last 12 months)$273.78KNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$42.59K Get NBTX Insider Trade Alerts Want to know when executives and insiders are buying or selling Nanobiotix stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data NBTX Institutional Buying and Selling by Quarter Nanobiotix Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/19/2025Jane Street Group LLC11,387$41K0.0%-51.1%0.024% 2/17/2025Millennium Management LLC13,452$39K0.0%N/A0.029% 2/14/2025Jane Street Group LLC23,283$73K0.0%N/A0.049% 2/12/2025Geode Capital Management LLC10,184$29K0.0%N/A0.022% 2/12/2025OLD Mission Capital LLC48,474$139K0.0%N/A0.103% 1/26/2024Baillie Gifford & Co.2,869,030$20.89M0.0%+48.2%6.087% 11/13/2023Baillie Gifford & Co.1,936,195$16.94M0.0%+38.3%5.350% 11/9/2023Johnson & Johnson959,637$8.40M3.1%N/A2.652% 8/17/2021Woodline Partners LP59,994$827K0.0%-7.0%0.174% 5/18/2021Millennium Management LLC22,082$332K0.0%-53.3%0.066% (Data available from 1/1/2016 forward) NBTX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of NBTX shares? During the previous two years, the following institutional investors and hedge funds held shares of Nanobiotix shares: Baillie Gifford & Co. ($20.89M), Johnson & Johnson ($8.40M), OLD Mission Capital LLC ($139K), Jane Street Group LLC ($41K), and Millennium Management LLC ($39K), Geode Capital Management LLC ($29K).Learn more on Nanobiotix's institutional investors. What percentage of Nanobiotix's stock is owned by institutional investors? 38.81% of Nanobiotix's stock is owned by institutional investors. Learn more on NBTX's institutional investor holdings. Which institutional investors have been buying Nanobiotix's stock? The following institutional investors have purchased Nanobiotix's stock in the last 24 months: Baillie Gifford & Co. ($1.47M), Johnson & Johnson ($959.64K), OLD Mission Capital LLC ($48.47K), Jane Street Group LLC ($23.28K), Millennium Management LLC ($13.45K), and Geode Capital Management LLC ($10.18K). How much institutional buying is happening at Nanobiotix? Institutional investors have bought a total of 95,393 shares in the last 24 months. This purchase volume represents approximately $273.78K in transactions. Which of Nanobiotix's major shareholders have been selling company stock? The following institutional investors have sold Nanobiotix stock in the last 24 months: Jane Street Group LLC ($11.90K). How much institutional selling is happening at Nanobiotix? Institutional investors have sold a total of 11,896 shares in the last 24 months. This volume of shares sold represents approximately $42.59K in transactions. Related Companies Zymeworks Institutional Ownership Spyre Therapeutics Institutional Ownership Verve Therapeutics Institutional Ownership Amphastar Pharmaceuticals Institutional Ownership Arcus Biosciences Institutional Ownership LENZ Therapeutics Institutional Ownership Oric Pharmaceuticals Institutional Ownership Anavex Life Sciences Institutional Ownership Replimune Group Institutional Ownership Mineralys Therapeutics Institutional Ownership This page (NASDAQ:NBTX) was last updated on 7/23/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?Bitcoin is breaking out — and one state just created a Strategic Crypto Reserve. James Altucher says this m...Paradigm Press | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nanobiotix S.A. Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Nanobiotix With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NBTX Stock Alerts